AAAAAA

   
Results: 1-16 |
Results: 16
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes
Authors: Mazzocchi, A Melani, C Rivoltini, L Castelli, C Del Vecchio, M Lombardo, C Colombo, MP Parmiani, G
Citation: A. Mazzocchi et al., Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes, CANCER IMMU, 50(4), 2001, pp. 199-211
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells
Authors: Castelli, C Ciupitu, AMT Rini, F Rivoltini, L Mazzocchi, A Kiessling, R Parmiani, G
Citation: C. Castelli et al., Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells, CANCER RES, 61(1), 2001, pp. 222-227
Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability ofclass I complexes at the cell surface
Authors: Hallermalm, K Seki, K Wei, CH Castelli, C Rivoltini, L Kiessling, R Levitskaya, J
Citation: K. Hallermalm et al., Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability ofclass I complexes at the cell surface, BLOOD, 98(4), 2001, pp. 1108-1115
Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cells
Authors: Nielsen, MB Kirkin, AF Loftus, D Nissen, MH Rivoltini, L Zeuthen, J Geisler, C Odum, N
Citation: Mb. Nielsen et al., Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cells, J IMMUNOTH, 23(4), 2000, pp. 405-411
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999)
Authors: Arienti, F Belli, F Napolitano, F Sule-Suso, J Mazzocchi, A Gallino, GF Cattelan, A Santantonio, C Rivoltini, L Melani, C Colombo, MP Cascinelli, N Maio, M Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells (vol 10, pg 2907, 1999), HUM GENE TH, 11(6), 2000, pp. 981-981
Cytokines in cancer therapy
Authors: Parmiani, G Rivoltini, L Andreola, G Carrabba, M
Citation: G. Parmiani et al., Cytokines in cancer therapy, IMMUNOL LET, 74(1), 2000, pp. 41-44
Quantitation of antigen-reactive T cells in peripheral blood by IFN gamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial
Authors: Scheibenbogen, C Romero, P Rivoltini, L Herr, W Schmittel, A Cerottini, JC Woelfel, T Eggermont, AMM Keilholz, U
Citation: C. Scheibenbogen et al., Quantitation of antigen-reactive T cells in peripheral blood by IFN gamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial, J IMMUNOL M, 244(1-2), 2000, pp. 81-89
T-cell recognition of melanoma-associated antigens
Authors: Castelli, C Rivoltini, L Andreola, G Carrabba, M Renkvist, N Parmiani, G
Citation: C. Castelli et al., T-cell recognition of melanoma-associated antigens, J CELL PHYS, 182(3), 2000, pp. 323-331
Murine granulocytes control human tumor growth in SCID mice
Authors: Lozupone, F Luciani, F Venditti, M Rivoltini, L Pupa, S Parmiani, G Belardelli, F Fais, S
Citation: F. Lozupone et al., Murine granulocytes control human tumor growth in SCID mice, INT J CANC, 87(4), 2000, pp. 569-573
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer
Authors: Nagorsen, D Keilholz, U Rivoltini, L Schmittel, A Letsch, A Asemissen, AM Berger, G Buhr, HJ Thiel, E Scheibenbogen, C
Citation: D. Nagorsen et al., Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer, CANCER RES, 60(17), 2000, pp. 4850-4854
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
Authors: Arienti, F Belli, F Napolitano, F Sule-Suso, J Mazzocchi, A Gallino, GF Cattelan, A Sanantonio, C Rivoltini, L Melani, C Colombo, MP Cascinelli, N Maio, M Parmiani, G
Citation: F. Arienti et al., Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells, HUM GENE TH, 10(18), 1999, pp. 2907-2916
Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998)
Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998), J IMMUNOL, 163(2), 1999, pp. 1093-1093
Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens
Authors: Castelli, C Tarsini, P Mazzocchi, A Rini, F Rivoltini, L Ravagnani, F Gallino, F Belli, F Parmiani, G
Citation: C. Castelli et al., Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens, J IMMUNOL, 162(3), 1999, pp. 1739-1748
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
Authors: Wang, ZG Marincola, FM Rivoltini, L Parmiani, G Ferrone, S
Citation: Zg. Wang et al., Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells, J EXP MED, 190(2), 1999, pp. 205-215
A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication formore effective immunotherapy
Authors: Rivoltini, L Squarcina, P Loftus, DJ Castelli, C Tarsini, P Mazzocchi, A Rini, F Viggiano, V Belli, F Parmiani, G
Citation: L. Rivoltini et al., A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication formore effective immunotherapy, CANCER RES, 59(2), 1999, pp. 301-306
Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide
Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide, J IMMUNOL, 161(12), 1998, pp. 6956-6962
Risultati: 1-16 |